FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
Investor's Business Daily on MSN2d
Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?In the meantime, its Covid vaccine has yet to hit a bottom and its RSV vaccine is coming from behind in competition with ...
Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...
The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...
"We remain focused on our three strategic priorities: driving sales growth, delivering up to 10 product approvals over the ...
It spreads through inhalation or contact with the fluids from an infected person's coughs or sneezes. 2 While often linked to ...
The article " After a Reset Year, Is Moderna Stock Poised for a Comeback? " first appeared on MarketBeat.
One-third of folks with major depressive disorder experience treatment-resistant depression (TRD), a condition that makes it ...
The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...
4don MSN
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...
We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback